Cognita (Citicoline) is indicated as an adjunctive therapy in the management of various forms of cognitive impairment and memory loss resulting from traumatic brain injury (TBI), cerebrovascular disorders, stroke, age-related cognitive decline, Alzheimer’s disease, Parkinson’s disease, and related conditions.
Why SPAMEDA Citicoline?
In this formulation, the incorporation of “Citicoline Sodium” substantially enhances solubility compared to free-base “Citicoline Acid,” thereby promoting superior absorption and bioavailability. In line with leading global pharmaceutical manufacturers, SPAMEDA (Salamat Parmoon Amin), a knowledge-based pharmaceutical company, has developed this advanced Citicoline Sodium tablet formulation.
Indications:
- Supports and enhances cognitive and brain functions
- Improves focus, concentration, and mental precision during daily tasks
- Aids in the recovery of cognitive and neurological deficits secondary to traumatic brain injury and cerebrovascular stroke
- Exerts neuroprotective effects against age-related cognitive impairment, Alzheimer’s disease, and vascular or degenerative dementias
- Serves as an adjunctive support to improve visual function in patients with glaucoma
